
View larger version (22K):
[in a new window]
|
Fig. 3. KCl-elicited [Ca2+]c rises through voltage-operated
calcium channels. After application of 60 mM KCl for 12 seconds ( ), the
KCl solution was reapplied under the presence of L-type Ca2+
channel (10 µM nifedipine, A), N-type Ca2+ channel (1 µM
-conotoxin GVIA, B), and P/Q-type Ca2+ channel (1 µM
-agatoxin IVA, C) antagonists, a cocktail of the above three
antagonists (D), or 100 µM CdCl2 (E). (F) Summary of the
inhibitions of the KCl-elicited [Ca2+]c rises by VOCC
antagonists; nifedipine (36.0±3.0% of control, n=10),
-conotoxin GVIA (69.5±8.8%, n=5), -agatoxin IVA
(92.3±6.6%, n=4), cocktail of the above three antagonists
(23.2±4.1%, n=3), and CdCl2 (15.0±2.7%,
n=4). *Significant difference (paired student t-test,
P<0.05). Nif, nifedipine; -cono GVIA, -conotoxin
GVIA; -aga IVA, -agatoxin IVA.
|